CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,825,450 | -15.6% | 503,240 | -6.5% | 0.10% | -17.3% |
| Q2 2023 | $17,557,389 | +0.7% | 538,240 | 0.0% | 0.13% | +5.0% |
| Q1 2023 | $17,433,536 | -24.4% | 538,240 | +7.0% | 0.12% | -22.4% |
| Q4 2022 | $23,057,377 | -5.4% | 503,240 | 0.0% | 0.16% | -9.3% |
| Q3 2022 | $24,383,000 | +19.2% | 503,240 | -3.3% | 0.17% | +2.4% |
| Q2 2022 | $20,449,000 | -13.2% | 520,476 | -18.7% | 0.17% | +5.0% |
| Q1 2022 | $23,566,000 | +0.7% | 640,228 | +24.7% | 0.16% | +7.4% |
| Q4 2021 | $23,398,000 | +27.5% | 513,344 | 0.0% | 0.15% | +19.2% |
| Q3 2021 | $18,346,000 | +80.6% | 513,344 | 0.0% | 0.12% | +78.6% |
| Q2 2021 | $10,159,000 | +35.4% | 513,344 | +36.6% | 0.07% | +12.9% |
| Q1 2021 | $7,502,000 | -4.0% | 375,853 | 0.0% | 0.06% | 0.0% |
| Q4 2020 | $7,811,000 | +157.3% | 375,853 | +168.0% | 0.06% | +113.8% |
| Q3 2020 | $3,036,000 | – | 140,225 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |